SCHEMBL26847371

SCHEMBL26847371

C=C1NC(c2cncc(CSc3[nH]c(=O)cc(-c4cccs4)c3C#N)c2)=NO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.39
▸ ALDH1A1 P00352 7/20 0.39
▸ HPGD P15428 6/20 0.39
▸ GAA P10253 3/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ GLA P06280 2/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ ACMSD Q8TDX5 6/20 0.38
▸ PIM1 P11309 2/20 0.37
▸ CYP2C19 P33261 1/20 0.36
▸ NPSR1 Q6W5P4 5/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ RXFP1 Q9HBX9 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ PRNP P04156 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847363 0.90 ACMSD (0.45) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL26847368 0.88 HSD11B1 (0.36) ALDH1A1HPGDACMSDCYP2C19MEN1
SCHEMBL26847313 0.87 ACMSD (0.32) ACMSDCYP2C19NPSR1MEN1KMT2A
SCHEMBL24088009 0.81 ACMSD (0.55) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL26847367 0.78 KMT2A (0.40) KDM4EALDH1A1HPGDACMSDMEN1
SCHEMBL26847309 0.77 ACMSD (0.39) KDM4EACMSDCYP2C19NPSR1MEN1
SCHEMBL17548432 0.73 ACMSD (0.68) KDM4EALDH1A1HPGDACMSDCYP2C19
SCHEMBL26847307 0.72 KMT2A (0.39) KDM4EALDH1A1HPGDACMSDMEN1
SCHEMBL24088014 0.72 ACMSD (0.68) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL26847199 0.71 ACMSD (0.48) KDM4EALDH1A1HPGDGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885HPGD 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback